Jean-Louis Vigne

Title: **Innovator Jean-Louis Vigne: Pioneering Advances in Pharmaceutical Technology**

Introduction

Jean-Louis Vigne is a distinguished inventor based in San Francisco, CA, known for his significant contributions to the field of pharmaceutical technology. With a total of two patents, his innovative work focuses on improving drug delivery systems and enhancing the production of therapeutic proteins.

Latest Patents

Jean-Louis Vigne's latest patents reflect his expertise in creating methods that optimize the administration and production of pharmaceutical agents. One of his notable patents is related to **Pharmaceutical microemulsions**, which outlines a method for the parenteral administration of fat-soluble pharmaceuticals and vitamins. This method utilizes microemulsions composed of naturally occurring amphipathic substances and hydrophobic lipids, allowing safe intravenous injection of active ingredients. The design of the microemulsions ensures that the distribution of the active ingredient in serum closely mimics its natural oral administration.

Another significant patent by Vigne addresses **Mature apoai protein production under serum-free culturing conditions**. This invention involves a method of producing purified lipid-binding peptides that can effectively bind to phospholipids. By introducing a specific gene coding for the peptide into a suitable expression system, Vigne has developed a technique for producing low-density lipopeptide complexes. These innovations are crucial for the scaled-up production of human apolipoproteins and their therapeutic applications.

Career Highlights

Throughout his career, Jean-Louis Vigne has established himself as a skilled inventor in the biotechnology sector. He works for California Biotechnology Inc., where he advances technologies that impact health care by innovating drug delivery and protein production methods. His dedication to improving pharmaceutical formulations showcases a profound understanding of both chemistry and biotechnology.

Collaborations

Vigne's work is often enhanced through collaboration with esteemed colleagues, including John P. Kane and Andrew Asher Protter. Together, they contribute to a robust research environment that fosters innovation and drives forward significant advancements in biotechnology.

Conclusion

Jean-Louis Vigne exemplifies the spirit of innovation in the biotechnology sector, with a focus on enhancing pharmaceutical delivery and protein synthesis. His patents not only reflect a depth of knowledge but also demonstrate a commitment to improving health care outcomes through advanced scientific approaches. As he continues his work at California Biotechnology Inc., his contributions are likely to result in significant advancements in the industry.